]>
IRCT2013091814704N1 IRCT 2015-05-17 Vice chancellor for research ,Shiraz University of Medical Science Effectiveness of long time using of splinting in severe CTS Our clinical trial is to evaluate the effectiveness of long term using of splinting in comparrison with short term usage of splinting in severe CTS in pt who do not accept surgical treatment. 2012-12-28 anticipated 140 Complete https://irct.ir/trial/14257 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment. 2-3 Carpal tunnel syndrome. Intervention 1: The intervention group will receive (naproxene 500mg 3times a day) for 10 days and vit B1 B6 tabs for 6month.They use splint for 6 months. Intervention 2: The control group:The patients use splint for 6 weeks.They will receive (naproxene 3 times a day) for 10 days and Vit B1 B6 for 6 months .
public Shahrzad Sanaee
Door plate:71, Street number 1, Jahad Sazandegi Avenue, Azadi plaza, Shiraz
Shiraz Iran (Islamic Republic of) 7144716699 +98 71 3227 4250 shahrzad.sanaee@gmail.com International branch of Shiraz University of Medical Science scientific Dr.Sharareh Roshanzamir
Physical medicne and Rehabilitation ward's off, second floor, Faghihi Hospital, Zand Avenue, Shiraz
Shiraz Iran (Islamic Republic of) +98 71 3235 1087 sharareh.roshanzamir@gmail.com Shiraz University of Medical Science Iran (Islamic Republic of) Inclusion criteria: patient with severe cts that did not accept surgical treatment Exclusion criteria:patient with previous surgery on the study hand or wrist; any mass; tumor; or deformity in the hand or wrist; any history of severe trauma to the wrist (such as fracture); polyneuropathy; cervical radiculopathy; pregnancy; or lactating; fibromyalgia; arthritis no limit no limit Both G56.0 Carpal tunnel syndrome Rehabilitation Rehabilitation The intervention group will receive (naproxene 500mg 3times a day) for 10 days and vit B1 B6 tabs for 6month.They use splint for 6 months The control group:The patients use splint for 6 weeks.They will receive (naproxene 3 times a day) for 10 days and Vit B1 B6 for 6 months . EMG and NCV are the primary outcomes measurements that at the end they determinate the efficacy of the splint for the study. Timepoint: at the begining and at the end. Method of measurement: CTSAQ,Boston questionaire. Clinical manifestations. Timepoint: every 2 weeks. Method of measurement: physical exam. Vice chancellor for research ,Shiraz University of Medical Science Approved 2014-08-03 Ethics committee of shiraz universty of medical science 3rd floor, managment building of shiraz university of medical sciences, Zand Avenue. Shiraz Iran (Islamic Republic of)